索引于
- 学术期刊数据库
- 打开 J 门
- Genamics 期刊搜索
- 学术钥匙
- 期刊目录
- 中国知网（CNKI）
- 引用因子
- 西马戈
- 乌尔里希的期刊目录
- 电子期刊图书馆
- 参考搜索
- 哈姆达大学
- 亚利桑那州EBSCO
- OCLC-WorldCat
- SWB 在线目录
- 虚拟生物学图书馆 (vifabio)
- 普布隆斯
- 米亚尔
- 大学教育资助委员会
- 日内瓦医学教育与研究基金会
- 欧洲酒吧
- 谷歌学术
分享此页面
期刊传单
抽象的
Bioequivalence and its evaluation
Macroni Laco
On the off chance that two medications are supposed to be bioequivalent if there is no clinically critical contrast in their bioavailability. Bio equivalency testing includes correlation of proportions of bioavailability of the nonexclusive and trailblazer details. For drug reciprocals to be bioequivalent, "the rate and degree of ingestion of the test drug should not show a critical distinction between the rate and degree of retention of the reference drug when regulated at similar molar portion of the remedial fixings under comparable trial conditions as either a solitary portion or different dosages
免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证